Cycurion Seeks Shareholder Approval for Highly Dilutive Warrant Exercise to Raise Up to $12M
CYCU is trading near its 52-week low of $2 (2.5% above the low) on light trading volume (0.1× avg).
Summary
Cycurion, Inc. has filed a definitive proxy statement to seek shareholder approval for the issuance of up to 3.3 million shares upon warrant exercise, which could raise approximately $12 million in critical capital.
Key Events · Financing and Capital Events · CYCU
-
Shareholder Vote Scheduled
A special meeting is set for February 26, 2026, to approve the issuance of up to 3,314,920 shares of common stock upon the exercise of warrants, as required by Nasdaq Listing Rule 5635(d).
-
Significant Capital Potential
Approval could enable the company to raise up to approximately $12 million in gross proceeds, a substantial amount relative to its current market capitalization, which is critical for funding operations.
-
Dilution and Premium Pricing
The potential issuance represents significant dilution for existing shareholders, but the warrants have an exercise price of $3.62 per share, which is at a premium to the current stock price of $2.05.
-
Finalizes Prior Disclosure
This definitive proxy statement finalizes the terms and pricing of the warrant offering initiated with a preliminary proxy statement on January 21, 2026.
Analysis · CYCU · Technology
This definitive proxy statement finalizes the terms for a critical shareholder vote on February 26, 2026, regarding the exercise of warrants from a December 2025 private placement. The approval is necessary to comply with Nasdaq rules and enable the company to potentially raise up to $12 million. While the issuance of 3.3 million shares represents substantial potential dilution (approximately 79% of current outstanding shares), the capital infusion is vital for Cycurion's operations, especially given its micro-cap status and current trading near 52-week lows. Notably, the warrant exercise price of $3.62 per share is at a significant premium to the current stock price of $2.05, indicating favorable terms for the original investors and a stronger capital raise if exercised. This follows a preliminary proxy statement filed on January 21, 2026, and a resale registration on January 2, 2026, both related to warrant shares.
At the time of this filing, CYCU was trading at $2.05 on NASDAQ in the Technology sector, with a market capitalization of approximately $7.4M. The 52-week trading range was $2.00 to $2,028.87. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.